Plants are becoming an accepted platform for the development of vaccine production. | |
A wide variety of human vaccine targets have been explored with promising outcomes. | |
Both influenza and SARS-CoV-2 have provided ideal opportunities to prove the applicability of the platform with encouraging results of plant-produced vaccines from phase III trials and authorisation for human use in Canada. |